West Pharmaceutical Services (WST) Other Working Capital Changes (2009 - 2026)

West Pharmaceutical Services has disclosed Other Working Capital Changes across 18 years of filings, most recently posting $102.9 million for Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at $102.9 million, up 103000.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $93.3 million (up 262.83% YoY), and the FY2025 annual result was -$9.7 million, up 57.08% from the prior year.
• Other Working Capital Changes came in at $102.9 million for Q1 2026 at West Pharmaceutical Services, up from -$11.6 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $102.9 million in Q1 2026 to a low of -$185.4 million in Q4 2022.
• The 5-year median for Other Working Capital Changes is $100000.0 (2024), against an average of $2.2 million.
• Across the five-year window, Other Working Capital Changes plunged 2200.0% in 2025 and jumped 103000.0% in 2026, its largest moves.
• West Pharmaceutical Services' Other Working Capital Changes stood at -$185.4 million in 2022, then soared by 85.98% to -$26.0 million in 2023, then slumped by 66.15% to -$43.2 million in 2024, then jumped by 73.15% to -$11.6 million in 2025, then soared by 987.07% to $102.9 million in 2026.
• The last three Other Working Capital Changes figures came in at $102.9 million (Q1 2026), -$11.6 million (Q4 2025), and -$2.1 million (Q3 2025), per Business Quant data.